Browse > Article
http://dx.doi.org/10.5352/JLS.2017.27.10.1215

Application of Transposable Elements as Molecular-marker for Cancer Diagnosis  

Kim, Hyemin (Department of Biological Sciences, College of Natural Sciences, Pusan National University)
Gim, Jeong-An (Department of Biological Sciences, College of Natural Sciences, Pusan National University)
Woo, Hyojeong (Department of Biological Sciences, College of Natural Sciences, Pusan National University)
Hong, Jeonghyeon (Department of Biological Sciences, College of Natural Sciences, Pusan National University)
Kim, Jinyeop (Department of Biological Sciences, College of Natural Sciences, Pusan National University)
Kim, Heui-Soo (Department of Biological Sciences, College of Natural Sciences, Pusan National University)
Publication Information
Journal of Life Science / v.27, no.10, 2017 , pp. 1215-1224 More about this Journal
Abstract
Until now, various oncogenic pathways were idenfied. The accumulation of DNA mutation induces genomic instability in the cell, and it makes cancer. The development of bioinformatics and genomics, to find the precise and reliable biomarker is available. This biomarker could be applied the early-dignosis, prediction and convalescence of cancer. Recently, Transposable elements (TEs) have been attracted as the regulator of genes, because they occupy a half of human genome, and the cause of various diseases. TEs induce DNA mutation, as well as the regulation of gene expression, that makes to cancer development. So, we confirmed the relationship between TEs and colon cancer, and provided the clue for colon cancer biomarker. First, we confirmed long interspersed nuclear element-1 (LINE-1), Alu, and long terminal repeats (LTRs) and their relationship to colon cancer. Because these elements have large composition and enormous effect to the human genome. Interestingly, colon cancer specific patterns were detected, such as the hypomethylation of LINE-1, LINE-1 insertion in the APC gene, hypo- or hypermethylation of Alu, and isoform derived from LTR insertion. Moreover, hypomethylation of LINE-1 in proto-oncogene is used as the biomarker of colon cancer metastasis, and MLH1 mutation induced by Alu is detected in familial or hereditary colon cancer. The genes, effected by TEs, were analyzed their expression patterns by in silico analysis. Then, we provided tissue- and gender-specific expression patterns. This information can provide reliable cancer biomarker, and apply to prediction and diagnosis of colon cancer.
Keywords
Alu element; colon cancer; long interspersed nuclear element-1; long terminal repeats; transposable elements;
Citations & Related Records
연도 인용수 순위
  • Reference
1 National Cancer Center. 2014. Annual report of cancer statistics in Korea in 2013. Goyang, Korea: National Cancer Center.
2 Nystrom-Lahti, M., Kristo, P., Nicolaides, N. C., Chang, S. Y., Aaltonen, L. A., Moisio, A. L., Jarvinen, H. J., Mecklin, J. P., Kinzler, K. W. and Vogelstein, B. 1995. Founding mutations and Alu-mediated recombination in hereditary colon cancer. Nat. Med. 1, 1203-1206.   DOI
3 Ostertag, E. M. and Kazazian Jr, H. H. 2001. Biology of mammalian L1 retrotransposons. Annu. Rev. Genet. 35, 501-538.   DOI
4 Perot, P., Mullins, C. S., Naville, M., Bressan, C., Huhns, M., Gock, M., Kuhn, F., Volff, J. N., Trillet-Lenoir, V. and Linnebacher, M. 2015. Expression of young HERV-H loci in the course of colorectal carcinoma and correlation with molecular subtypes. Oncotarget 6, 40095.   DOI
5 Peltomaki, P. 2003. Role of DNA mismatch repair defects in the pathogenesis of human cancer. J. Clin. Oncol. 21, 1174-1179.   DOI
6 Rodriguez, J., Vives, L., Jorda, M., Morales, C., Munoz, M., Vendrell, E. and Peinado, M. A. 2008. Genome-wide tracking of unmethylated DNA Alu repeats in normal and cancer cells. Nucleic Acids Res. 36, 770-784.   DOI
7 Salmon, A., Clotault, J., Jenczewski, E., Chable, V. and Manzanares-Dauleux, M. J. 2008. Brassica oleracea displays a high level of DNA methylation polymorphism. Plant Sci. 174, 61-70.   DOI
8 Signorini, L., Villani, S., Bregni, M., Ferrante, P. and Delbue, S. 2016. Do the human endogenous retroviruses play a role in colon cancer? Adv. Tumor Virol. 6, 11.   DOI
9 Slotkin, R. K. and Martienssen, R. 2007. Transposable elements and the epigenetic regulation of the genome. Nat. Rev. Genet. 8, 272-285.
10 Suter, C. M., Martin, D. I. and Ward, R. L. 2004. Hypomethylation of L1 retrotransposons in colorectal cancer and adjacent normal tissue. Int. J. Colorectal Dis. 19, 95-101.   DOI
11 Swergold, G. D. 1990. Identification, characterization, and cell specificity of a human LINE-1 promoter. Mol. Cell. Biol. 10, 6718-6729.   DOI
12 Swets, M., Zaalberg, A., Boot, A., Van Wezel, T., Frouws, M. A., Bastiaannet, E., Gelderblom, H., Van De Velde, C. J. and Kuppen, P. J. 2016. Tumor LINE-1 methylation level in association with survival of patients with stage II colon cancer. Int. J. Mol. Sci. 18, 36.   DOI
13 Thorsen, K., Sorensen, K. D., Brems-Eskildsen, A. S., Modin, C., Gaustadnes, M., Hein, A. M. K., Kruhoffer, M., Laurberg, S., Borre, M. and Wang, K. 2008. Alternative splicing in colon, bladder, and prostate cancer identified by exon array analysis. Mol. Cell. Proteomics 7, 1214-1224.   DOI
14 Wong, J. J. L., Hawkins, N. J. and Ward, R. L. 2007. Colorectal cancer: a model for epigenetic tumorigenesis. Gut 56, 140-148.   DOI
15 Umar, A., Buermeyer, A. B., Simon, J. A., Thomas, D. C., Clark, A. B., Liskay, R. M. and Kunkel, T. A. 1996. Requirement for PCNA in DNA mismatch repair at a step preceding DNA resynthesis. Cell 87, 65-73.   DOI
16 van den Hurk, J. A., van de Pol, D. J., Wissinger, B., van Driel, M. A., Hoefsloot, L. H., de Wijs, I. J., van den Born, L. I., Heckenlively, J. R., Brunner, H. G. and Zrenner, E. 2003. Novel types of mutation in the choroideremia (CHM) gene: a full-length L1 insertion and an intronic mutation activating a cryptic exon. Hum. Genet. 113, 268-275.   DOI
17 Wolff, E. M., Byun, H. M., Han, H. F., Sharma, S., Nichols, P. W., Siegmund, K. D., Yang, A. S., Jones, P. A. and Liang, G. 2010. Hypomethylation of a LINE-1 promoter activates an alternate transcript of the MET oncogene in bladders with cancer. PLoS Genet. 6, e1000917.   DOI
18 Sverdlov, E. D. 2000. Retroviruses and primate evolution. Bioessays 22, 161-171.   DOI
19 Xing, J., Hedges, D. J., Han, K., Wang, H., Cordaux, R. and Batzer, M. A. 2004. Alu element mutation spectra: molecular clocks and the effect of DNA methylation. J. Mol. Biol. 344, 675-682.   DOI
20 Yamaguchi, J., Nagayama, S., Chino, A., Sakata, A., Yamamoto, N., Sato, Y., Ashihara, Y., Kita, M., Nomura, S. and Ishikawa, Y. 2014. Identification of coding exon 3 duplication in the BMPR1A gene in a patient with juvenile polyposis syndrome. Jpn. J. Clin. Oncol. 44, 1004-1008.   DOI
21 Zhuo, C., Li, Q., Wu, Y., Li, Y., Nie, J., Li, D., Peng, J., Lian, P., Li, B. and Cai, G. 2015. LINE-1 hypomethylation in normal colon mucosa is associated with poor survival in Chinese patients with sporadic colon cancer. Oncotarget 6, 23820.   DOI
22 Chen, J. M., Stenson, P. D., Cooper, D. N. and Ferec, C. 2005. A systematic analysis of LINE-1 endonuclease-dependent retrotranspositional events causing human genetic disease. Hum. Genet. 117, 411-427.   DOI
23 Batzer, M. A. and Deininger, P. L. 2002. Alu repeats and human genomic diversity. Nat. Rev. Genet. 3, 370-379.   DOI
24 Boxus, M. and Willems, L. 2009. Mechanisms of HTLV-1 persistence and transformation. Br. J. Cancer 101, 1497-1501.   DOI
25 Chenais, B. 2013. Transposable elements and human cancer: a causal relationship? Biochim. Biophys. Acta-Rev. Cancer 1835, 28-35.   DOI
26 Cruickshanks, H. A., Vafadar-Isfahani, N., Dunican, D. S., Lee, A., Sproul, D., Lund, J. N., Meehan, R. R. and Tufarelli, C. 2013. Expression of a large LINE-1-driven antisense RNA is linked to epigenetic silencing of the metastasis suppressor gene TFPI-2 in cancer. Nucleic Acids Res. 41, 6857-6869.   DOI
27 Feinberg, A. P. and Vogelstein, B. 1983. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 301, 89-92.   DOI
28 Hedges, D. and Deininger, P. 2007. Inviting instability: Transposable elements, double-strand breaks, and the maintenance of genome integrity. Mutat. Res. 616, 46-59.   DOI
29 World Health Organization. 2014. GLOBOCAN 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012. Lyon, France: International Agency for Research on Cancer.
30 Hulsken, J., Birchmeier, W. and Behrens, J. 1994. E-cadherin and APC compete for the interaction with beta-catenin and the cytoskeleton. J. Cell Biol. 127, 2061-2069.   DOI
31 Kazazian, H. H. 2004. Mobile elements: drivers of genome evolution. Science 303, 1626-1632.   DOI
32 Hur, K., Cejas, P., Feliu, J., Moreno-Rubio, J., Burgos, E., Boland, C. R. and Goel, A. 2014. Hypomethylation of long interspersed nuclear element-1 (LINE-1) leads to activation of proto-oncogenes in human colorectal cancer metastasis. Gut 63, 635-646.   DOI
33 Jordan, I. K., Rogozin, I. B., Glazko, G. V. and Koonin, E. V. 2003. Origin of a substantial fraction of human regulatory sequences from transposable elements. Trends Genet. 19, 68-72.   DOI
34 Jung, Y. D., Huh, J. W., Kim, D. S., Kim, Y. J., Ahn, K., Ha, H. S., Lee, J. R., Yi, J. M., Moon, J. W. and Kim, T. O. 2011. Quantitative analysis of transcript variants of CHM gene containing LTR12C element in humans. Gene 489, 1-5.   DOI
35 Kloor, M., Sutter, C., Wentzensen, N., Cremer, F. W., Buckowitz, A., Keller, M., von Knebel Doeberitz, M. and Gebert, J. 2004. A large MSH2 Alu insertion mutation causes HNPCC in a German kindred. Hum. Genet. 115, 432-438.   DOI
36 Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., Baldwin, J., Devon, K., Dewar, K., Doyle, M. and FitzHugh, W. 2001. Initial sequencing and analysis of the human genome. Nature 409, 860-921.   DOI
37 Lin, X., Stenvang, J., Rasmussen, M. H., Zhu, S., Jensen, N. F., Tarpgaard, L. S., Yang, G., Belling, K., Andersen, C. L. and Li, J. 2015. The potential role of Alu Y in the development of resistance to SN38 (Irinotecan) or oxaliplatin in colorectal cancer. BMC Genomics 16, 404.   DOI
38 Lerat, E. and Semon, M. 2007. Influence of the transposable element neighborhood on human gene expression in normal and tumor tissues. Gene 396, 303-311.   DOI
39 Li, L., McVety, S., Younan, R., Liang, P., Du Sart, D., Gordon, P. H., Hutter, P., Hogervorst, F. B., Chong, G. and Foulkes, W. D. 2006. Distinct patterns of germ line deletions in MLH1 and MSH2: the implication of Alu repetitive element in the genetic etiology of Lynch syndrome (HNPCC). Hum. Mutat. 27, 388-388.
40 Liang, Q., Ding, J., Xu, R., Xu, Z. and Zheng, S. 2009. Identification of a novel human endogenous retrovirus and promoter activity of its 5′U3. Biochem. Biophys. Res. Commun. 382, 468-472.   DOI
41 Matlik, K., Redik, K. and Speek, M. 2006. L1 antisense promoter drives tissue-specific transcription of human genes. J. Biomed. Biotecnol. 2006, 71753.
42 Mauillon, J. L., Michel, P., Limacher, J. M., Latouche, J. B., Dechelotte, P., Charbonnier, F., Martin, C., Moreau, V., Metayer, J. and Paillot, B. 1996. Identification of novel germline hMLH1 mutations including a 22 kb Alu-mediated deletion in patients with familial colorectal cancer. Cancer Res. 56, 5728-5733.
43 Miki, Y., Nishisho, I., Horii, A., Miyoshi, Y., Utsunomiya, J., Kinzler, K. W., Vogelstein, B. and Nakamura, Y. 1992. Disruption of the APC gene by a retrotransposal insertion of L1 sequence in a colon cancer. Cancer Res. 52, 643-645.
44 Liang, Q., Xu, Z., Xu, R., Wu, L. and Zheng, S. 2012. Expression patterns of non-coding spliced transcripts from human endogenous retrovirus HERV-H elements in colon cancer. PLoS One 7, e29950.   DOI
45 Mills, R. E., Bennett, E. A., Iskow, R. C. and Devine, S. E. 2007. Which transposable elements are active in the human genome? Trends Genet. 23, 183-191.   DOI
46 Mori, Y., Nagse, H., Ando, H., Horii, A., Ichii, S., Nakatsuru, S., Aoki, T., Miki, Y., Mori, T. and Nakamura, Y. 1992. Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene. Hum. Mol. Genet. 1, 229-233.   DOI
47 Moussa, S. A. B., Moussa, A., Lovecchio, T., Kourda, N., Najjar, T., Jilani, S. B., El Gaaied, A., Porchet, N., Manai, M. and Buisine, M. P. 2009. Identification and characterization of a novel MLH1 genomic rearrangement as the cause of HNPCC in a Tunisian family: evidence for a homologous Alu-mediated recombination. Fam. Cancer 8, 119-126.   DOI